Raymond James Maintains Strong Buy on DexCom, Lowers Price Target to $131

Benzinga · 09/15/2023 11:24
Raymond James analyst Jayson Bedford maintains DexCom (NASDAQ:DXCM) with a Strong Buy and lowers the price target from $154 to $131.